Lv6
1700 积分 2021-08-13 加入
Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer
20天前
已完结
Flowchart for endometrial cancer classification integrating FIGO 2023 staging and ESGO/ESTRO/ESP 2025 risk categories
2个月前
已完结
A dual-responsive AI-designed peptide P9-conjugate disrupts E6–E6AP Interface to restore p53 and suppress HPV16-driven cervical cancer
2个月前
已完结
Flowchart for endometrial cancer classification integrating FIGO 2023 staging and ESGO/ESTRO/ESP 2025 risk categories
2个月前
已完结
Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263)
4个月前
已完结
Randomized Phase III Trial of Adjuvant Radiation versus Chemoradiation in Intermediate-Risk, Early-stage Cervical Cancer following Radical Hysterectomy and Lymphadenectomy: Results from NRG Oncology/GOG-263/KGOG1008
4个月前
已完结
Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer
4个月前
已完结
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
4个月前
已完结
Clearer Horizons: The latest advances in clear cell ovarian cancer treatment
4个月前
已完结
Combination Therapy for Platinum-Resistant Ovarian Cancer: A Novel At-Home Regimen with Envafolimab, Lenvatinib, and Etoposide
4个月前
已完结
皖公网安备34019202002308
